TL;DR
UVB light exposure, a common trigger for flares in Systemic Lupus Erythematosus (SLE), initiates a potent Type I Interferon (IFN-I) response in the skin, blood, and kidneys. This early response is largely dependent on the cGAS-STING pathway, suggesting a novel mechanism linking UV damage to systemic inflammation in SLE.
What Problem Does This Paper Address?
Many SLE patients experience photosensitivity, where exposure to ultraviolet B (UVB) light exacerbates their skin disease and triggers systemic flares. However, the precise molecular mechanisms linking skin exposure to systemic inflammation in SLE have remained unclear. While Type I Interferons (IFN-I) are known to be elevated in SLE patients and are implicated in disease pathogenesis, the trigger for their production in response to UV light and their systemic dissemination were not fully understood. This study investigates how acute UVB exposure initiates an IFN-I response, its dependence on specific cellular pathways, and its spread from the skin to other organs.
Methods
The researchers employed a multi-pronged approach using mouse models and human skin samples:
- Acute UVB Irradiation Model: C57BL/6J mice (both male and female) were exposed to a single, controlled dose of UVB light. This contrasts with previous studies using repeated low-dose exposure, which can confound results with repair processes.
- Gene Expression Analysis (qPCR and RNA Sequencing): They measured the expression levels of Type I Interferon-stimulated genes (ISGs) in skin, blood, and kidney tissues at various time points post-UVB exposure. RNA sequencing was used for a broader analysis of IFN-I response genes in human skin.
- Genetic Knockout Models: They utilized cGAS-deficient (cGAS-/-) and IFN-α/β receptor-deficient (Ifnar1-/-) mice to determine the role of these specific pathways in the IFN-I response.
- Pharmacological Inhibition: They used an ENPP1 inhibitor (STF-1084) to block the hydrolysis of extracellular cGAMP, a product of cGAS, to assess its contribution to the IFN-I response. Hydroxychloroquine (HCQ), known to inhibit cGAS, was also used.
- Immunofluorescence Staining: IFN-β protein levels were visualized in mouse skin tissue.
- Flow Cytometry: Immune cell infiltration into the skin was analyzed by quantifying specific immune cell populations.
- Human Phototesting: Healthy volunteers were exposed to UVB light, and skin biopsies were analyzed for IFN-I signatures.
Datasets
- Mouse Skin, Blood, and Kidney Samples: Collected from C57BL/6J mice (wild-type, cGAS-/-, Ifnar1-/-) at various time points after acute UVB exposure.
- Human Skin Biopsies: Obtained from healthy volunteers after controlled UVB exposure.
- RNA Sequencing Data: Generated from human skin biopsies. The raw data is available on the NCBI GEO database under accession number GSE148535.
Key Insights and Ideas
- UVB as a Potent Systemic IFN-I Inducer: A single, acute UVB exposure is sufficient to trigger a robust IFN-I response not only locally in the skin but also systemically in the blood and kidneys. This highlights a direct link between external UV insult and internal immune signaling.
- Sex-Dependent Response: The early IFN-I response to UVB is significantly exaggerated in female mice compared to males, mirroring the higher prevalence of SLE in women. This suggests a potential biological basis for sex differences in photosensitivity and disease flares.
- cGAS-STING Pathway is Crucial: The early IFN-I response in the skin and, to a significant extent, in the blood, is critically dependent on the cyclic GMP-AMP synthase (cGAS) pathway. This indicates that DNA damage induced by UV light is recognized by cGAS, initiating a cascade leading to IFN-I production.
- Extracellular cGAMP Amplifies the Response: Inhibiting the breakdown of extracellular cGAMP (a cGAS product) by ENPP1 amplifies the IFN-I response, suggesting that the release and persistence of cGAMP play a role in modulating the intensity of the inflammatory signal.
- cGAS Influences Immune Cell Infiltration: The absence of cGAS leads to reduced infiltration of innate immune cells (neutrophils, monocytes) into the UV-injured skin, suggesting that cGAS-mediated signaling, possibly through IFN-I, is important for orchestrating the early inflammatory response.
- Human Relevance: The study demonstrates that acute UVB exposure also induces an IFN-I signature in healthy human skin, validating the mouse model and suggesting that this mechanism is conserved across species.
Key Results
- A single UVB dose induced a ~10-fold increase in ISG expression in mouse skin, which persisted for days.
- The early IFN-I response (at 6 hours) was approximately 10-fold higher in female mice compared to males.
- In cGAS-/- mice, the early (6-hour) ISG expression in the skin was almost completely abrogated, and significantly reduced at 24 hours.
- Systemic ISG expression was observed in the blood and kidneys of UVB-exposed mice.
- Hydroxychloroquine (HCQ), an inhibitor of cGAS, significantly reduced the early IFN-I response in both skin and blood.
- Inhibition of ENPP1 (cGAMP hydrolysis) significantly enhanced UVB-induced ISG expression in the skin.
- UVB exposure induced an IFN-I signature in human skin as early as 6 hours post-exposure.
- The absence of cGAS led to a significant reduction in neutrophil and inflammatory monocyte infiltration into UV-exposed skin.
Limitations and Future Work
- Cellular Source of IFN-I: While the study implicates cGAS, the specific cell types producing IFN-I in response to UVB in the skin and blood are not definitively identified. Future work could focus on dissecting the cellular origins of IFN-I.
- Role of Other Sensors: The study acknowledges that cGAS is not the sole contributor to the IFN-I response, particularly at later time points. Investigating the roles of other DNA and RNA sensors (e.g., AIM2, IFI16, RIG-I) in this context is warranted.
- Protein Level Confirmation: While mRNA levels of inflammatory cytokines were measured, protein levels were not extensively analyzed. Future studies could confirm these findings at the protein level.
- Chronic vs. Acute Responses: The study focuses on acute responses. Understanding how these mechanisms contribute to chronic inflammation in conditions like SLE requires further investigation.
- Therapeutic Implications: The findings suggest that targeting the cGAS-STING pathway or modulating cGAMP levels could be potential therapeutic strategies for managing UV-induced inflammation and flares in SLE. Further research into the efficacy and safety of such interventions is needed.
Summary updated